Carnivac-Cov[1][2][3] or Karnivak-Kov[4][3] is the first veterinary vaccine against COVID-19.[3] It is an inactivated vaccine for carnivores such as dogs, cats, foxes, arctic foxes and mink.[1] It was developed by the Federal Service for Veterinary and Phytosanitary Supervision of Russia[5] to help prevent mutations in animals that can occur in cross-species transmission,[1][3] as is suspected to have occurred with the Cluster 5 variant in Denmark in November 2020.[4]
The vaccine is given in 2 doses 21 days apart.[2] In trials, the tested animals sustained an immune response for at least six months.[1] The full course costs 500 ₽ (US$7).[2]
Clinical trials on animals began in October 2020.[6] The vaccine was registered in Russia on 31 March 2021,[1] where production began on 30 April[7] and administration began on 26 May.[8]